We have a library of over 200 quality standards and a single menu of indicators. They can be used to help define and measure quality in health, public health and social care. They can be used by ...

We’ve issued final draft guidance recommending a new once-a-day tablet that is set to benefit around 1,100 people with a type ...

New analysis presented by the company, together with an improved discount to the price of vamorolone, mean that NICE can now ...

NICE is proposing changes to its routing criteria for Highly Specialised Technologies (HST) to ensure more consistent, ...

Anhydrous sodium thiosulfate, also known as Pedmarqsi and made by Norgine, is recommended in final draft guidance for preventing hearing loss caused by cisplatin chemotherapy in children from the ages ...

Cost-effectiveness thresholds play a vital role in healthcare decision-making, helping to ensure that NHS resources are used ...

Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer TA1021 4 December 2024 4 December 2024 ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments TA1023 11 December 2024 11 December 2024 ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.